| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/01/2013 | EP2585091A1 Sustained-release formulation |
| 05/01/2013 | EP2585090A1 Keloid treatment |
| 05/01/2013 | EP2585089A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 05/01/2013 | EP2585083A1 A method for preparing a bone protein preparation and a bone protein preparation |
| 05/01/2013 | EP2585053A2 Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones |
| 05/01/2013 | EP2585044A1 Long-term storage of non-glycosylated recombinant human g-csf |
| 05/01/2013 | CN202909115U Die for producing cyclosporine self-microemulsifying soft capsules |
| 05/01/2013 | CN103080309A Partial region polypeptide of REIC/DKK-3 protein |
| 05/01/2013 | CN103080194A Collagen powder and/or collagen-derived powder, and production method for same |
| 05/01/2013 | CN103080125A Short and D-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 05/01/2013 | CN103079588A An ancestral serine protease coagulation cascade exerts a novel function in early immune defense |
| 05/01/2013 | CN103079587A Glucagon superfamily peptides exhibiting nuclear hormone receptor activity |
| 05/01/2013 | CN103079585A Designer osteogenic proteins |
| 05/01/2013 | CN103079584A Method to detect endothelial cell massive calcium accumulation death |
| 05/01/2013 | CN103079577A Process,tube and device for the preparation of wound healant composition |
| 05/01/2013 | CN103079551A Combination of HDAC inhibitors with thrombocytopenia drugs |
| 05/01/2013 | CN103076213A Preparation method of glycosylated albumin quality control |
| 05/01/2013 | CN103073646A Polypeptide carrying melittin, nano-particles carrying melittin, and applications thereof |
| 05/01/2013 | CN103073645A Biologically mineralized insulin protein nano particle and preparation method and application thereof |
| 05/01/2013 | CN103073632A Potential novel cytokine LYG1 with anti-inflammatory and anti-tumor activities, and application thereof |
| 05/01/2013 | CN103073631A Hemopoietin analogue |
| 05/01/2013 | CN103073629A Protein capable of inhibiting release of virus particles, coding sequence of protein and application in inhibiting release of retrovirus from cells |
| 05/01/2013 | CN103073621A Minced tuna protein antioxidative peptide and its preparation method and use |
| 05/01/2013 | CN103073617A N-(2)-L-alanyl-L-glutamine compound |
| 05/01/2013 | CN103071150A Chinese patent medicine for treating Alzheimer's disease |
| 05/01/2013 | CN103071149A Collagen and squalane composition, preparations thereof, and preparation methods and applications of composition and preparations |
| 05/01/2013 | CN103071148A Compound thymosin Alpha 1 injection for improving livability of piglet and preparation method |
| 05/01/2013 | CN103071147A Continuous subcutaneous administration of interferon-alpha to hepatitis b infected patients |
| 05/01/2013 | CN103071146A Caspofungin acetate composition and preparation method thereof |
| 05/01/2013 | CN103071145A N(2)-L-alanyl-L-glutamine/compound amino acid injection (18AA-V) pharmaceutical composite preparation |
| 05/01/2013 | CN103071144A Marine functional food capable of inhibiting prostatic cancer and preparation method of marine functional food |
| 05/01/2013 | CN103070837A Triptorelin Acetate slow release dripping pills |
| 05/01/2013 | CN103070835A Freeze-dried composition containing bortezomib and preparation method of freeze-dried composition |
| 05/01/2013 | CN103070822A Argatroban injection and preparation method thereof |
| 05/01/2013 | CN102698253B Adenosine disodium triphosphate composition |
| 05/01/2013 | CN102363040B Antimicrobial peptide preparation for mucosal tissues |
| 05/01/2013 | CN102357244B Healthcare product for irregular menstruation |
| 05/01/2013 | CN102335412B Health-care product for otitis media |
| 05/01/2013 | CN102319423B Health care product for treating habitual constipation caused by internal heat due to yin deficiency |
| 05/01/2013 | CN102233130B Stable pharmaceutical preparation containing thymosin 1 derivatives |
| 05/01/2013 | CN102199196B Gene engineering antibacterial peptide and preparation method and application thereof |
| 05/01/2013 | CN102190718B Recombined litopenaeus setiferus protein SF-P9, preparation method and application thereof |
| 05/01/2013 | CN102166346B Lrrc10 micromolecules and application thereof to preparation of medicaments for treating myocardial hypertrophy |
| 05/01/2013 | CN102166201B Oral ciclosporin A sustained-release agent and preparation method thereof |
| 05/01/2013 | CN102018953B Pharmaceutical composition containing nocathiacin antibiotics |
| 05/01/2013 | CN101732697B Compound frozen ossotide preparation |
| 05/01/2013 | CN101730711B Preprocalcitonin antigen T epitopes |
| 05/01/2013 | CN101683522B Novel albumin-free factor VIII formulations |
| 05/01/2013 | CN101646446B Rankl产生抑制剂 Rankl production inhibitors |
| 05/01/2013 | CN101607995B Monoclonal antibody or binding activity fragment thereof of H5 subtype avian influenza virus hemagglutinin protein and application thereof |
| 05/01/2013 | CN101603042B RNA interference target for treating hepatitis B virus infection |
| 05/01/2013 | CN101535340B Erythropoietin compositions |
| 05/01/2013 | CN101487020B Preparation and use of recombinant gold needle mushroom immunomodulatory protein |
| 05/01/2013 | CN101466389B Formulation comprising whey protein and hydrolysates for improving muscle recovery |
| 05/01/2013 | CN101426513B Composition containing peptide as active ingredient |
| 05/01/2013 | CN101384617B Multimeric complexes of antigens and an adjuvant |
| 05/01/2013 | CN101384272B Methods and compositions for delivering active agents with enhanced pharmacological properties |
| 05/01/2013 | CN101376020B Application of fungal immunomodulatory protein for inhibiting delta 5-desaturated enzyme |
| 05/01/2013 | CN101233229B Processes for the manufacture of sterilized pancreatin powder |
| 05/01/2013 | CN101111512B Methods of using macrocyclic modulators of the ghrelin receptor |
| 04/30/2013 | US8431688 Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis |
| 04/30/2013 | US8431685 Polymer-based sustained release device |
| 04/30/2013 | US8431684 Process for the preparation of ibodutant (MEN15596) and related intermediates |
| 04/30/2013 | US8431615 Dose forms |
| 04/30/2013 | US8431545 Copolymer including uncharged hydrophilic block and cationic polyamino acid block having hydrophobic group in part of side chains, and use thereof |
| 04/30/2013 | US8431540 Modified lysine-mimetic compounds |
| 04/30/2013 | US8431539 Formulations of daptomycin |
| 04/30/2013 | US8431538 HDAC inhibitors and therapeutic methods of using same |
| 04/30/2013 | US8431537 Glue composition for lung volume reduction |
| 04/30/2013 | US8431536 Target for breast cancer therapy and/or diagnosis |
| 04/30/2013 | US8431535 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 04/30/2013 | US8431534 GRF-containing lyophilized pharmaceutical compositions |
| 04/30/2013 | US8431533 GLP-1 fusion peptides, their production and use |
| 04/30/2013 | US8431532 FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same |
| 04/30/2013 | US8431531 Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same |
| 04/30/2013 | US8431529 Bi-dentate compounds as kinase inhibitors |
| 04/30/2013 | US8431528 Antibacterial Lactobacillus GG peptides and methods of use |
| 04/30/2013 | US8431527 Methods for alleviating deleterious effects of 3-deoxyglucosone |
| 04/30/2013 | US8431525 Coelenteramide analogs |
| 04/30/2013 | US8431524 Peptide antagonist of interleukin-15 activity |
| 04/30/2013 | US8431523 Oligomeric biosurfactants in dermatocosmetic compositions |
| 04/30/2013 | US8431522 Methods of inhibiting tumor cell proliferation |
| 04/30/2013 | US8431521 Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adducts |
| 04/30/2013 | US8431396 Anti-angiogenic peptides |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431359 Nucleotide sequences coding tissue factor pathway inhibitor for use in treatment and prevention of blood disorders |
| 04/30/2013 | US8431354 Bacterial pheromones and uses therefor |
| 04/30/2013 | US8431221 Therapeutic calcium phosphate particles and methods of manufacture and use |
| 04/30/2013 | US8431170 Antimicrobial composition with low cytotoxicity |
| 04/30/2013 | US8431161 Microparticle and pharmaceutical composition thereof |
| 04/30/2013 | US8431146 Scaffold comprising co-precipitated Collgen and glycosaminoglycan for inhibiting adhesion of body tissue layers |
| 04/30/2013 | US8431129 Method of treating fibroproliferative disorders of the heart and lung |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | US8431123 Method for treating systemic bacterial, fungal and protozoan infection |
| 04/30/2013 | US8431122 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/30/2013 | US8431112 Photostabilization of cholecalciferol with alkoxycrylene compounds |
| 04/30/2013 | CA2557174C Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same |
| 04/30/2013 | CA2531023C Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 04/30/2013 | CA2515608C Stem cell factor for preventing chemotherapy-induced depletion of blood cells |